Danila Valmori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Danila Valmori has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Maha Ayyoub
Université de Toulouse, CNRS, Inserm, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France
7 shared publications Charles S. Hesdorffer
Ludwig Institute Clinical Trial Center, Department of Medicine, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building Room 20-09, New York, NY 10032, USA
6 shared publicationsLloyd J. Old
Ludwig Institute Clinical Trial Center, Department of Medicine, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building Room 20-09, New York, NY 10032, USA
5 shared publicationsNaira E. Souleimanian
Ludwig Institute Clinical Trial Center, Department of Medicine, Columbia University College of Physicians and Surgeons, 650 West 168th Street, Black Building Room 20-09, New York, NY 10032, USA
5 shared publicationsAndrea Merlo
2 shared publications- Emmanuelle Godefroy
Nantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001
2 shared publications
Latest Publications
- 28 February 2007
- Published by Elsevier in Clinical Immunology
- Vol. 122 (2) , 163-172
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen
- 28 February 2007
- Published by Elsevier in Clinical Immunology
- Vol. 122 (2) , 163-172
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen
- 1 February 2006
- Published by Elsevier in Clinical Immunology
- Vol. 118 (2-3) , 188-194
A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients
- 1 February 2006
- Published by Elsevier in Clinical Immunology
- Vol. 118 (2-3) , 188-194
A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients
- 30 November 2005
- Published by Elsevier in Clinical Immunology
- Vol. 117 (2) , 161-167
Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals
- 30 November 2005
- Published by Elsevier in Clinical Immunology
- Vol. 117 (2) , 161-167
Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals
- 1 October 2005
- Published by Elsevier in Clinical Immunology
- Vol. 117 (1) , 24-30
Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses
- 1 October 2005
- Published by Elsevier in Clinical Immunology
- Vol. 117 (1) , 24-30
Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses
- Open Access
- 1 July 2005
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 115 (7) , 1953-1962
A peripheral circulating compartment of natural naive CD4+ Tregs
CD4+CD25+ Tregs play a central role in the maintenance of peripheral self tolerance by keeping autoreactive T cells in check. Whereas the thymic origin of CD4+CD25+ Tregs, as a distinct lineage, has been inferred, understanding of their developmental pathways has remained elusive. In both mice and humans, peripheral CD4+CD25+ Treg populations have been described as composed of antigen-experienced T cells that fail to significantly proliferate following TCR stimulation but suppress proliferation and effector functions of CD25– T cells. Here we show that analysis of CD25 expression in human circulating CD4+ T lymphocytes with respect to their in vivo differentiation stages identifies a distinct subset of CD25+CCR7+CD62L+CTLA-4+FOXP3+ cells contained in the CD45RA+/RO– naive fraction. The subset, which we have named natural naive Tregs (NnTregs), is prominent in young adults and decreases with age together with the total naive CD4+ population. NnTregs are anergic following stimulation in the absence of IL-2 and exert ex vivo cell-cell contact–mediated suppressor functions. In addition, they proliferate in response to stimulation with autologous APCs, which indicates a high enrichment in T cells bearing self-reactive TCRs. The definition of this subset has important implications for the analysis of human naturally occurring Tregs and for their targeting in therapeutic immune interventions.
- 1 July 2005
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 115 (7) , 1953-1962
Open AccessA peripheral circulating compartment of natural naive CD4+ Tregs
CD4+CD25+ Tregs play a central role in the maintenance of peripheral self tolerance by keeping autoreactive T cells in check. Whereas the thymic origin of CD4+CD25+ Tregs, as a distinct lineage, has been inferred, understanding of their developmental pathways has remained elusive. In both mice and humans, peripheral CD4+CD25+ Treg populations have been described as composed of antigen-experienced T cells that fail to significantly proliferate following TCR stimulation but suppress proliferation and effector functions of CD25– T cells. Here we show that analysis of CD25 expression in human circulating CD4+ T lymphocytes with respect to their in vivo differentiation stages identifies a distinct subset of CD25+CCR7+CD62L+CTLA-4+FOXP3+ cells contained in the CD45RA+/RO– naive fraction. The subset, which we have named natural naive Tregs (NnTregs), is prominent in young adults and decreases with age together with the total naive CD4+ population. NnTregs are anergic following stimulation in the absence of IL-2 and exert ex vivo cell-cell contact–mediated suppressor functions. In addition, they proliferate in response to stimulation with autologous APCs, which indicates a high enrichment in T cells bearing self-reactive TCRs. The definition of this subset has important implications for the analysis of human naturally occurring Tregs and for their targeting in therapeutic immune interventions.
- 31 January 2005
- Published by Elsevier in Clinical Immunology
- Vol. 114 (1) , 70-78
Distinct but overlapping T helper epitopes in the 37–58 region of SSX-2
- 31 January 2005
- Published by Elsevier in Clinical Immunology
- Vol. 114 (1) , 70-78
Distinct but overlapping T helper epitopes in the 37–58 region of SSX-2
- Open Access
- 30 November 2004
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 1 (2) , e26
Using Modified Antigenic Sequences to Develop Cancer Vaccines: Are We Losing the Focus?
Are short synthetic peptides the key to developing cancer vaccines? And what are the obstacles in the way?
- 30 November 2004
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 1 (2) , e26
Open AccessUsing Modified Antigenic Sequences to Develop Cancer Vaccines: Are We Losing the Focus?
Are short synthetic peptides the key to developing cancer vaccines? And what are the obstacles in the way?